Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de Saint Etienne

About this trial

Chronic fatigue is enhanced by adapted physical activity (APA) programs. Patients consulting on St Etienne hospital and suffering from fibromyalgia and long Covid benefit from a 4-6 week APA program, with 2 sessions per week. While most patients are improved by these exercise-training programs, for some the benefits remain very modest, and patients describe persistent fatigue. The literature unanimously describes the necessity of longer APA protocols (8-12 weeks, 2-3 sessions/week) for fatigue reduction in fibromyalgia and long Covid. However, it seems difficult to adhere to an optimal program as described in the literature for these fatigued patients. The investigators want to test a device that would both reduce fatigue and improve recovery between APA sessions, in order to gradually reach the recommendations for APA practice. Transcutaneous vagal nerve stimulation (tVNS) seems to be a promising approach. Thus, combining an APA intervention with a tVNS protocol could potentiate the expected and now well-known effect of exercise.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient over 18 years old

Signature of informed consent

Confirmed diagnosis of fibromyalgia or long Covid (ACR 2016 criteria and persistent symptoms lasting more than 6 months after a positive RT-PCR test, respectively)

Persistent fatigue after an exercise rehabilitation program (FSS score > 36)

Disqualifiers

Pre-existing atrial fibrillation,

Left ventricular ejection fraction <40%

Severe heart failure

Recent stroke or myocardial infarction (<6 months)

Trial design

Design model

Parallel

Treatments tested in this trial

  • APA program

    Other intervention

    An APA program of 12 weeks, 2 sessions of 1h/week for mixed endurance, strengthening and stretching work. The program can be realized at home or in structure.

  • Active transcutaneous VNS

    Other intervention

    After each APA session, a 1h-tVNS session is delivered on the conchae aurea of the left ear, in resting condition. Parameters of tVNS : frequency 20Hz, impulsion 200ms, amplitude 1mA below the unpleasant sensation level.

  • Sham transcutaneous VNS

    Other intervention

    After each APA session, a 1h-tVNS session is delivered on the left earlobe, in resting condition. Parameters of tVNS : frequency 20Hz, impulsion 200ms, amplitude 1mA below the unpleasant sensation level.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Patients with active tVNSExperimental treatment 2 interventions
Group B: Patients with sham tVNSSham comparator 2 interventions

Trial outcomes

Primary outcomes

1

Fatigue evaluation assessed by autonomic nervous system activity

The root mean square of successive differences in heart rate (in milliseconds) will be measured from a nocturnal Holter ECG recording (Novacor, Paris, France) at the end of the 3-month APA and tVNS programme (month 3) and compared with pre-programme values (inclusion).

Time frame
Month : 0; 3

Secondary outcomes

1

Fatigue Severity Scale (FSS)

Subjective fatigue assessed by FSS, score from 9 to 63. The higher the score, the more severe the fatigue is and the more it affects the person's activities.

Time frame
Month : 0; 6
2

Medical Outcome Study Short Form questionnaire (MOS-SF 12)

Quality of life assessed by the MOS-SF 12 questionnaire , score from 0 to 100. A low score reflects a perception of poor health, loss of function and the presence of pain. A high score reflects a perception of good health, absence of functional deficit and pain.

Time frame
Month : 0; 6
3

Pittsburgh questionnaire

Quality of sleep assessed by Pittsburgh questionnaire (score 0 to 21). The 7 components of the score add up to give an overall score ranging from give an overall score ranging from 0 to 21 points, with 0 meaning that there are no difficulties, and 21 indicating major difficulties.

Time frame
Month : 0; 6
4

6-minute walk test (6MWT)

Physical condition assessed by the walking distance covered in the 6MWT, walking distance in m.

Time frame
Month : 0; 6

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.